Research Funding Announcements | Lewy Body Dementia Association LBDA

Research Funding Announcements

Stay up-to-date on LBD-relevant funding opportunity announcements from LBDA and federal agencies like the National Institutes of Health and Department of Defense.

LBDA

None at this time. For future funding opportunities, please note LBDA's Policy on Indirect Rates.

NATIONAL INSTITUTES OF HEALTH

Title: Notice of Special Interest: Administrative Supplements for NIA-VA Mentored Physician-Scientist Award in Alzheimer’s Disease and its Related Dementias (AD/ADRD)
Notice Number:
 
NOT-AG-19-011
Issued by: National Institute on Aging (NIA)
Activity Code: VA IK2; NIA administrative supplement
Description The purpose of this initiative is to increase the number of early stage physician-scientists in Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD) research and improve patient care for veterans. To accomplish this goal, NIA and the U.S. Department of Veterans Affairs (VA) have created a two-part opportunity for early career VA physician-scientists to pair with both VA- and NIA-funded mentors in the AD/ADRD field . This will also facilitate the development of a sustainable process for collaboration and address key barriers or challenges that often hinder communication, sharing of resources, and increased coordination between the VA and NIA.
Open Date (Earliest Submission Date): October 1, 2019
Letters of Intent Due Date: March 9, 2020 for Spring Cycle
Application Due Date(s) Dates are aligned with the VA receipt dates for funding in FY 2020 – for Spring Cycle - May 6, 2020, by 5:00 PM local time of the applicant organization.
Funds Available and Anticipated Number of Awards Up to 10 awards
Award Budget: IK2 award - $65,000/year
NIA administrative supplement – up to $185,000 a year
Award Project Period: Up to 5 years
 
Scientific/Research Contacts Lisa A. Opanashuk, Ph.D. 
National Institute on Aging (NIA)
Telephone: 301-827-5422
Email: Lisa.Opanashuk@nih.gov
Title: Notice of Intent to Publish a Funding Opportunity Announcement for Impact of Alcohol on the Onset and Progression of Alzheimer’s Disease and Its Related Dementias (R01 - Clinical Trial Optional)
Notice Number:
 
OT-AA-19-026
Issued by: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Aging (NIA)
Activity Code: R01
Description National Institute on Alcohol Abuse and Alcoholism (NIAAA) in partnership with the National Institute on Aging (NIA) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications to investigate mechanisms underlying the influence of alcohol on the onset and progression of Alzheimer’s disease and its related dementias.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and appropriate projects.

The FOA is expected to be published in Fall 2019 with an expected application due date in Spring 2020.

This FOA will utilize the R01 activity code. Details of the planned FOA are provided below.

Funds Available and Anticipated Number of Awards $3 million for 6-8 awards
Award Budget: $250,00 direct costs/year
Scientific/Research Contacts Changhai Cui, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
301-443-1678
Email: changhai.cui@nih.gov
 
Bradley C. Wise, Ph.D.
National Institute of Aging (NIA)
Telephone:301-496-9350
Email: WiseB@nia.nih.gov
Title: Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
Notice Number:
 
PAR-19-374
Issued by: National Institute on Aging (NIA)
Activity Code: U19
Description This FOA allows for applications that propose large-scale, complex research projects with multiple highly integrated components focused on a common research question relevant to aging. Such projects will likely involve an integrated multidisciplinary team of investigators within a single institution or a consortium of institutions. Resources and study expertise will be tightly coordinated across multiple sites or cores, such as:

  • One or more coordinating centers
  • Clinical or study sites
  • Specialized cores, such as for data management and analysis, measurement and phenotyping, animal models, etc.

Examples of the kinds of studies supported under this announcement include, but are not limited to, one or a combination of the following:
 
Large-scale longitudinal observational studies of diseases or conditions that are common in aging populations involving integration of multiple clinical outcomes with molecular, genetic, or other mechanistic data.

  • Large-scale, multi-site intervention studies in human subjects and/or animal models for aging-related conditions involving multiple endpoints to assess efficacy or effectiveness and to elucidate mechanisms.
  • Translation of basic science findings into pre-clinical or clinical studies, or of clinical findings into practice or community settings, for prevention, diagnosis, or treatment of aging-related conditions, requiring coordination of broad multidisciplinary expertise across multiple settings.

The structure and approach of proposed projects will vary depending on the hypotheses under study; however, it is expected that all projects will focus on an overarching scientific question that integrates all study components into a unified whole.

Open Date (Earliest Submission Date): September 28, 2019
Letters of Intent Due Date: 30 days prior to the application due date
Application Due Date(s) January 25, 2020.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Award Project Period: The maximum project period is 5 years.  
Scientific/Research Contacts Sanoj Suneja, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-402-7710
Email: sunejas@mail.nih.gov
Title: Notice of Intent to Publish a Funding Opportunity Announcement for Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial not allowed)
Notice Number:
 
NOT-MH-19-043
Issued by: National Institute of Mental Health (NIMH)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Activity Code: R01
Description The NIMH and NIAAA intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for research on the development of PET and SPECT tracers for molecular targets (e.g., receptors, intracellular messengers, disease-related proteins) that are implicated in mental disorders and alcohol abuse as tools to study disease pathophysiology and/or for assessing target engagement of potential therapeutic candidates. The objective of this FOA is to stimulate research in the identification and development of PET and SPECT probes for disorders of primary interest to the NIMH or NIAAA.
 
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
 
The FOA is expected to be published in January 8, 2020 with an expected application due date in February 5, 2020 .
Open Date (Earliest Submission Date): The FOA is expected to be published in January 8, 2020
Application Due Date(s) The expected application due date will be February 5, 2020 .
Scientific/Research Contacts Enrique Michelotti, PhD
NIMH
301- 443- 5415
michelottiel@mail.nih.gov
Title: Low Cost Detection of Cognitive Decline in Clinical Settings (R61/R33 Clinical Trial Required)
Notice Number:
 
RFA-AG-20-050
Issued by: National Institute on Aging (NIA)
Activity Code: R61/R33 Exploratory/Developmental  Phased Award
Description This Funding Opportunity Announcement (FOA) invites applications to pursue development and validation studies of cognitive screening instruments or assessments in clinical settings and to translate these screening and assessment tools into electronic health record (EHR) systems that can assist physicians in making clinically meaningful care recommendations for patients experiencing cognitive decline.
 
This FOA will support an R61 pilot phase (Stage I) which will allow researchers to develop and validate tools for cognitive assessment and then create scalable, tailored interventions for patients experiencing cognitive decline to help overcome barriers to uptake. If successful, researchers may transition to an R33 phase (Stage IV) for implementation of pragmatic trials. All applicants are required to address health disparities. This FOA does not require preliminary data.
 
The transition from the R61 to the R33 phase of the award will be administratively reviewed for successful completion of the go/no-go criteria specified for the R61 phase.
Open Date (Earliest Submission Date): December 30, 2019
Letters of Intent Due Date: December 30, 2019
Application Due Date(s) January 30, 2020
Funds Available and Anticipated Number of Awards NIA intends to commit $4M in FY 2020 to fund 3-4 awards.
Award Budget: For the R61 planning phase, the combined budget for direct costs may not exceed $750,000, with no more than $500,000 requested in any single year.
For the R33 implementation phase, the combined budget for direct costs may not exceed $3M. 
 
Applicant's budgets need to reflect the actual needs of the proposed project.
Award Project Period: The maximum project period for the R61 planning phase is 2 years.
 
The maximum project period for the R33 phase is 3 years.
Scientific/Research Contacts Partha Bhattacharyya, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-3136
Email: bhattacharyyap@mail.nih.gov
Title: Low Cost Detection of Cognitive Decline in Clinical Settings (R01 Clinical Trial Required)
Notice Number:
 
RFA-AG-20-051
Issued by: National Institute on Aging (NIA)
Activity Code: R01
Description This Funding Opportunity Announcement (FOA) invites applications to pursue validation studies of cognitive screening instruments or assessments in clinical settings and to translate these screening and assessment tools into electronic health record (EHR) systems that can assist physicians in making clinically meaningful care recommendations for patients experiencing cognitive decline. This FOA requires prior preliminary data gathered during the development of cognitive screening tools and/or assessments. This FOA will also support research to validate these tools as well as their implementation in large clinical settings. Plans for validation of cognitive impairment against relevant Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) biomarkers are encouraged but not required.
Open Date (Earliest Submission Date): December 30, 2019
Letters of Intent Due Date: December 30, 2019
Application Due Date(s) January 30,2020
Funds Available and Anticipated Number of Awards  
NIA intends to commit $4 million in FY 2020 to fund 2-3 awards.
Award Budget: Applicant's budgets may not exceed $2 million per year in direct costs and may not exceed $4.25 million in total direct costs across five years.     Applicant's budgets need to reflect the actual needs of the proposed project.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Scientific/Research Contacts Partha Bhattacharyya, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-3136
Email: bhattacharyyap@mail.nih.gov
Title: Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed)
Notice Number:
 
PAR-19-372
Issued by: National Institute on Minority Health and Health Disparities (NIMHD)
National Institute on Aging (NIA)
National Human Genome Research Institute (NHGRI)
Activity Code: R01
Description The purpose of this Funding Opportunity Announcement (FOA) is to support and accelerate human epigenomic investigations focused on identifying and characterizing the mechanisms by which social experiences at various stages in life, both positive and negative, affect gene function and thereby influence health trajectories or modify disease risk in racial/ethnic minority and other health disparity populations.
Open Date (Earliest Submission Date): October 06, 2019
Application Due Date(s) November 6, 2020, November 8, 2021
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is 5 years
Scientific/Research Contacts Rina Das, PhD
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-496-3996
Email: dasr2@mail.nih.gov
 
Lucia Hindorff, Ph.D.
National Human Genome Research Institute
Phone: 240-271-1509
Email: hindorffl@mail.nih.gov
 
Amelia Karraker, PhD
National Institute on Aging (NIA)
Telephone: 301-496-3138
Email: Amelia.Karraker@nih.gov
Title: NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required)
Notice Number:
 
PAR-20-050
Issued by: National Institute of Neurological Disorders and Stroke (NINDS)
Activity Code: K01
Description The purpose of the NINDS Postdoctoral Mentored Career Development Award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program.
Open Date (Earliest Submission Date): January 12, 2020
Letters of Intent Due Date: N/A
Application Due Date(s) Standard dates apply. The first standard due date for this FOA is February 12, 2020.
 
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Award budgets are composed of salary and other program-related expenses.
Award Project Period: The total project period may not exceed 48 months.
Scientific/Research Contacts Stephen Korn, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Email: korns@ninds.nih.gov
Title: NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed)
Notice Number:
 
PAR-20-049
Issued by: National Institute of Neurological Disorders and Stroke (NINDS)
Activity Code: K01
Description The purpose of the NINDS Postdoctoral Mentored Career Development Award is to support the ability of outstanding, mentored postdoctoral researchers to develop a potentially impactful research project with a comprehensive career development plan that will enable them to launch an independent research program.
Open Date (Earliest Submission Date): January 12, 2020
Letters of Intent Due Date: N/A
Application Due Date(s) Standard dates apply. The first standard due date for this FOA is February 12, 2020.
 
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Award budgets are composed of salary and other program-related expenses.
Award Project Period: The total project period may not exceed 48 months.
Scientific/Research Contacts Stephen Korn, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Email: korns@ninds.nih.gov
Title: Leadership Award for Alzheimer's Disease and Related Dementias Research (R35 Clinical Trial Not Allowed)
Notice Number:
 
RFA-AG-21
Issued by: National Institute on Aging (NIA)
Activity Code: R35
Description NIA is seeking applications from investigators looking to enhance their research programs to address selected NIH Alzheimer's Disease and Related Dementias Research Implementation Milestones. Investigators will be provided protected time to produce a program of investigation specific to selected goals/milestones. Investigators and their institutions will also be expected to advance more junior researchers' capacity to address selected goals/milestones.
Open Date (Earliest Submission Date): May 19, 2020
Letters of Intent Due Date: May 19, 2020
Application Due Date(s) June 19, 2020
Funds Available and Anticipated Number of Awards NIA intends to commit $5 million in FY 2021 to fund 8-10 awards.
Award Budget: Applicants may request up to $600,000 in directs costs per year. Investigators are encouraged to request what is well justified for their research program. The award amount will be determined by NIA and commensurate with current NIA support of the PD/PI.
Award Project Period: Applications may request a maximum project period of five years.
Scientific/Research Contacts Cerise Elliott, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: elliottce@nih.gov
Title: Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed)
Notice Number:
 
RFA-NS-20-007
Issued by: National Institute of Neurological Disorders and Stroke (NINDS)
Activity Code: R61/R33 Exploratory/Developmental  Phased Award
Description This RFA invites applications from multidisciplinary teams to perform secondary data analysis, using existing datasets from two or more multi-site clinical research projects, including clinical trials, natural history studies, and/or comparative effectiveness research. Secondary analyses should address scientific and / or clinical hypotheses that can advance the understanding or care of neurological disorders and conditions within the NINDS mission. In this phased funding mechanism, applications are required to systematically and comprehensively perform cross-project data harmonization and curation, assessed using go/no-go data-quality metrics, prior to funding of the second phase of analyses. Consistent with the FAIR (findable, accessible, interoperable and reusable) data principles, this funding opportunity expects open-source cataloging of the processes and tools used for harmonization, curation, and analysis, as well as controlled access to the curated datasets.
Open Date (Earliest Submission Date): February 17, 2020
Application Due Date(s) February 17, 2020
Funds Available and Anticipated Number of Awards NINDS intends to commit a total of $1.5 million in FY 2020 to fund 2-3 awards.
Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Award Project Period: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Scientific/Research Contacts Patrick Frost Bellgowan, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: (301) 496-1447
Email: patrick.frostbellgowan@nih.gov
Title: A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease and Related Dementias (AD/ADRD) (R61/R33 Clinical Trials Optional)
Notice Number:
 
RFA-AG-20-026
Issued by: National Institute on Aging (NIA)
Activity Code: R61/R33 Exploratory/Developmental  Phased Award
Description The overall goal of this FOA is to support the development of a collaborative research and resource network to synergize the expertise, skills, and resources of investigators within the geriatric emergency medicine and Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) research communities to identify and address research gaps towards optimizing recognition and emergency care of older adults with AD/ADRD. 
Open Date (Earliest Submission Date): January 03, 2020
Letters of Intent Due Date: January 3, 2020
Application Due Date(s) February 3, 2020, by 5:00 PM local time of applicant organization.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
NIA intends to commit $1,500,000 in FY 2020 to fund one R61/R33 award.
Award Budget: For the R61 planning phase, the combined budget for direct costs may not exceed $1,000,000 a year.
For the R33 phase, the combined budget for direct costs may not exceed $1,000,000 a year.
Award Project Period: The maximum project period is 5 years. The R61 phase may be 1-2 years, and the R33 phase may be 3-4 years.
Scientific/Research Contacts Susan Zieman, M.D., Ph.D.
Division of Geriatrics and Clinical Gerontology
National Institute on Aging (NIA)
Telephone: 301-496-6761
Email: susan.zieman@nih.gov
Nina Silverberg, Ph.D.
Director, Alzheimer's Disease Centers Program
Division of Neuroscience
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: SilverbergN@mail.nih.gov
Title: Aging Research Dissertation Awards to Increase Diversity (R36 Clinical Trial Not Allowed)
Notice Number:
 
PAR-19-394
Issued by: National Institute on Aging (NIA)
Activity Code: R36 Dissertation Award
Description The purpose of this Funding Opportunity Announcement (FOA) is to provide dissertation awards in all areas of research within NIA’s strategic priorities to increase the diversity of the scientific research workforce engaged in research on aging and aging-related health conditions.
Open Date (Earliest Submission Date): January 16, 2020
                                                                                                         
Letters of Intent Due Date: N/A
Application Due Date(s) Standard dates apply, by 5:00 PM local time of applicant organization.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: This FOA allows for budget requests to cover, per year, a salary consistent with the current fiscal year National Research Service Award (NRSA) predoctoral stipend level (https://grants.nih.gov/training/nrsa.htm#policy) and up to $20,000 for additional expenses such as fringe benefits (including health insurance for self and family members), travel to scientific meetings, and dissertation research costs in accordance with institutional policies. With the exception of costs associated with the dissertation (i.e., dissertation credits), no funds may be used to pay tuition or fees.
Award Project Period: Support is provided for up to two years.
Scientific/Research Contacts Shahrooz Vahedi, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9322
Email:shahrooz.vahedi@nih.gov
Title: NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
Notice Number:
 
PAR-20-021
Issued by: National Institute of Neurological Disorders and Stroke (NINDS)
Activity Code: F32 Postdoctoral Individual National Research Service Award
Description The purpose of this award is to support outstanding scientific training of highly promising postdoctoral candidates with outstanding mentors. Candidates are eligible to apply for support from this program from ~12 months prior to the start of the proposed postdoctoral position to within 12 months after starting in the proposed postdoctoral position.  This NINDS F32 seeks to foster early, goal-directed planning and to encourage applications for bold and/or innovative projects by the candidate that have the potential for significant impact. Inclusion of preliminary data is strongly discouraged; rather, this F32 seeks innovative research ideas and thoughtful plans for training and mentorship that will facilitate the development of the postdoctoral fellow into an outstanding scientist. 
Open Date (Earliest Submission Date): JanuaryA 11, 2020
Application Due Date(s) February 11, 2020, June 9, 2020, and October 14, 2020, February 11, 2021, June 9, 2021, October 14, 2021, February 9, 2022, June 8, 2022, and October 11, 2022.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Award budgets are composed of stipends, tuition and fees, and institutional allowance.
Award Project Period: Individuals may receive up to 3 years of aggregate Kirschstein-NRSA support at the postdoctoral level, including any combination of support from institutional training grants (e.g., T32) and an individual fellowship award. 
Scientific/Research Contacts Stephen Korn, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-4188
Email: korns@ninds.nih.gov
Title: NIA Behavioral and Social Research LEaders in Alzheimers Disease and Its Related Dementias (NIA BSR LEADR) (DP1 - Clinical Trial Not Allowed)
Notice Number:
 
RFA-AG-20-033
Issued by: National Institute on Aging (NIA)
Activity Code: DP1                         
Description The NIA Behavioral and Social Research LEaders in Alzheimer’s Disease and Its Related Dementias (NIA BSR LEADR) program supports individual scientists of exceptional creativity who propose to use behavioral and social science perspectives and approaches for highly innovative, impactful, and potentially transformative theoretical, empirical, and clinical research addressing the challenges raised by AD/ADRD for individuals, their families, and society, such as the priority areas listed below. NIA encourages applications on a variety of AD/ADRD-related topics in which behavioral and social research can contribute, such as dementia care, dementia caregiver research, cognitive and dementia epidemiology, behavioral and social pathways of AD/ADRD, early psychological changes preceding AD/ADRD, prevention of AD/ADRD, and disparities in AD/ADRD or dementia-related outcomes.
Open Date (Earliest Submission Date): January 03, 2020
Letters of Intent Due Date: January 03, 2020
Application Due Date(s) February 3, 2020
Funds Available and Anticipated Number of Awards NIA intends to commit $1.6 million in total costs in FY 2020 to fund 2 awards.
Award Budget: Awards will be for a maximum of $500,000 in direct costs per year, plus applicable Facilities and Administrative (F&A) costs.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Scientific/Research Contacts Georgeanne E. Patmios
National Institute on Aging (NIA)
Telephone: 301-496-3136
Email: PatmiosG@mail.nih.gov
Title: Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed)
Notice Number:
 
PAS-19-391
Issued by: National Institute on Aging (NIA)
Activity Code: R03 Small Grant Program
Description This Small Research Grant (R03) will support important and innovative projects to provide needed scientific insight to improve the prevention, diagnosis, treatment, and/or care for individuals with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Specifically, this FOA will support archiving and leveraging existing data sets for analyses of projects covering a wide array of topics relating to AD/ADRD. The overall goal of this FOA is (i) to encourage the next generation of U.S. researchers to pursue research and academic careers in neuroscience, AD/ADRD, and healthy brain aging and (ii) to stimulate established researchers who are not currently doing AD/ADRD research to perform pilot studies developing new, innovative AD/ADRD research programs that leverage and build upon their existing expertise.
Open Date (Earliest Submission Date): January 16, 2020
Letters of Intent Due Date: N/A
Application Due Date(s) Standard dates apply, by 5:00 PM local time of applicant organization.
Funds Available and Anticipated Number of Awards NIH intends to fund an estimated 12 awards for this FOA and its companions, corresponding to a total of $1.8 million, for fiscal year 2020. Future year amounts will depend on annual appropriations.
Award Budget: Applications may request budgets of up to $100,000 in direct costs per year for up to two years.
Award Project Period: The scope of the project should determine the project period. The maximum project period is 2 years.
Scientific/Research Contacts Partha Bhattacharyya, Ph.D.
Division of Behavioral and Social Research
National Institute on Aging (NIA)
Telephone: 301-496-3136
Email: bhattacharyyap@mail.nih.gov
Title: Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Basic Science (R03 Clinical Trials Not Allowed)
Notice Number:
 
PAS-19-392
Issued by: National Institute on Aging (NIA)
Activity Code: R03 Small Grant Program
Description This Small Research Grant (R03) will support important and innovative projects focused on basic science approaches to elucidate neurodegenerative mechanisms/pathways of Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Proposed projects should ultimately aim to improve the prevention, diagnosis, treatment, and/or care for individuals with AD/ADRD. The program seeks (i) to facilitate the next generation of researchers in the United States to pursue research and academic careers in neuroscience, AD/ADRD, and healthy brain aging and (ii) to stimulate established researchers who are not currently doing AD/ADRD research to perform pilot studies toward developing new, innovative AD/ADRD research programs that leverage and build upon their existing expertise. 
Open Date (Earliest Submission Date): January 16, 2020
Letters of Intent Due Date: N/A
Application Due Date(s) Standard dates apply, by 5:00 PM local time of applicant organization.
Funds Available and Anticipated Number of Awards NIH intends to fund an estimated 12 awards for this FOA and its companions, corresponding to a total of $1.8 million, for fiscal year 2020. Future year amounts will depend on annual appropriations..
 
Award Budget: Applications may request budgets of up to $100,000 in direct costs per year for up to two years.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is 2 years.
Scientific/Research Contacts Lisa Opanashuk, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-807-5422
Email: lisa.opanashuk@nih.gov
Title: Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed)
Notice Number:
 
PAS-19-393
Issued by: National Institute on Aging (NIA)
Activity Code: R03 Small Grant Program
Description This Small Research Grant Program (R03) will support important and innovative system biology projects in which more scientific insight is needed to improve the prevention, diagnosis, treatment, and care for individuals with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The overall goal of this R03 program is (i) to facilitate the next generation of researchers in the United States to pursue research and academic careers in neuroscience, AD/ADRD, and healthy brain aging and (ii) to stimulate established researchers who are not currently doing AD/ADRD research to perform pilot studies toward developing new, innovative AD/ADRD research programs that leverage and build upon their existing expertise.
Open Date (Earliest Submission Date): January 16, 2020
Letters of Intent Due Date: N/A
Application Due Date(s) Standard dates apply, by 5:00 PM local time of applicant organization. 
Funds Available and Anticipated Number of Awards NIH intends to fund an estimated 12 awards for this FOA and its companions, corresponding to a total of $1.8 million, for fiscal year 2020. Future year amounts will depend on annual appropriations.
Award Budget: Applications may request budgets of up to $100,000 in direct costs per year for up to two years.
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is 2 years.
Scientific/Research Contacts Alison Yao, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9350
Email: alison.yao@nih.gov
Title: Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
Notice Number:
 
PAR-19-374             
Issued by: National Institute on Aging (NIA)
Activity Code: U19 Research Program – Cooperative Agreements
Description This FOA allows for applications that propose large-scale, complex research projects with multiple highly integrated components focused on a common research question relevant to aging. Such projects will likely involve an integrated multidisciplinary team of investigators within a single institution or a consortium of institutions.
Open Date (Earliest Submission Date): September 28, 2019
Letters of Intent Due Date: 30 days prior to the application due date
Application Due Date(s) New Dates The first submission date for this FOA is October 28, 2019. Thereafter, Standard dates apply.
 
After this off-cycle application due date, future application due dates will follow the standard due dates, with the next submission date of January 25, 2020.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.
Award Project Period: The maximum project period is 5 years.  
Scientific/Research Contacts Sanoj Suneja, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-402-7710
Email: sunejas@mail.nih.gov
Title: Notice of Special Interest: Alzheimer’s-focused administrative supplements for NIH grants that are not focused on Alzheimer’s disease
Notice Number:
 
NOT-AG-20-008
Issued by: NIA, NINDS and many other institutes
Description The participating Institutes and Centers (ICs) are inviting applications to expand existing awards that are not currently focused on Alzheimer’s disease and its related dementias (AD/ADRD)—frontotemporal dementia, Lewy body dementia, vascular cognitive impairment with dementia, and multiple etiology dementias—to allow the research to develop such a focus. Active awards with project end dates in FY 2021 or later are eligible.
First Available Due Date: March 06, 2020
Scientific/Research Contacts See NIH webpage for this notice
Title: Improving Quality of Care and Patient Outcomes During Care Transitions (R01)
Notice Number:
 
PA-20-068
Issued by: Agency for Healthcare Research and Quality (AHRQ)
Activity Code: R01
Description This Funding Opportunity Announcement (FOA) invites R01 grant applications for funding health services research that improves the quality of care and patient outcomes during transitions of care. The purpose of this FOA is to support large-scale research projects that rigorously test promising interventions aimed at improving communication and coordination during care transitions.
 
This FOA is focused on three research areas of interest

  • Care transitions between primary care, acute care, and specialty providers
  • Care transitions between different institutional care settings
  • Care transitions with a focus on patients, their families and communities
Open Date (Earliest Submission Date): December 6, 2019
Letters of Intent Due Date: n/a
Application Due Date(s) Standard dates apply. (Expiration date: December 6, 2022)
Funds Available and Anticipated Number of Awards The number of awards is contingent upon the submission of a sufficient number of meritorious applications and the availability of funds. Future year funding will depend on funding availability.
Award Budget: The total costs (direct and indirect) for a project awarded under this FOA will not exceed $400,000 in any given year and $2 million for the entire project period.
Award Project Period: The project period may not exceed 5 years.
Scientific/Research Contacts CDR Derrick L. Wyatt
Agency for Healthcare Research and Quality
Center for Evidence and Practice Improvement (CEPI)
Division of Health Information Technology
Telephone: 301-427-1506
Email: DigitalHealthcareResearch@ahrq.hhs.gov (preferred method of contact)
Title: NIA Research Centers Collaborative Network (RCCN) (U24 Clinical Trial Optional)
Notice Number:
 
RFA-AG-21-001
Issued by: National Institute on Aging (NIA)
Activity Code: U24
Description The purpose of this FOA is to support a network to enhance collaborations across NIA's 6 centers programs. These collaborations are intended to leverage NIA's substantial investments by fostering and sustaining the development of novel interdisciplinary efforts in aging research. This opportunity will provide resources to build additional infrastructure and establish specific collaborative activities that could include, but are not limited to, information and data exchange, meetings and conferences, pilot studies, research opportunities for early investigators, visiting scholar programs, dissemination, and other collaborative efforts. The successful awardee will involve all 6 centers programs:

  1. Alzheimer's Disease Centers
  2. Claude D. Pepper Older Americans Independence Centers (OAICs)
  3. Nathan Shock Centers of Excellence in the Basic Biology of Aging
  4. Resource Centers for Minority Aging Research (RCMARs)
  5. Edward R. Roybal Centers for Translation Research in the Behavioral and Social Sciences of Aging
  6. Centers on the Demography and Economics of Aging

This FOA supports new cross-center collaborative efforts. These efforts may embody a variety of themes, such as pre-clinical-to-clinical translation, clinical-to-community translation, enhancement of diversity in subject recruitment and the research workforce, and the cellular and molecular biology of aging, to name a few. These themes could encompass many different interdisciplinary efforts.

Open Date (Earliest Submission Date): April 15, 2020
Letters of Intent Due Date: April 15, 2020
Application Due Date(s) May 15, 2020
Funds Available and Anticipated Number of Awards NIA intends to commit $1 million in FY2021 to fund 1 award.
Award Budget: Application budgets are limited to $675,000 in annual direct costs.
Award Project Period: The maximum project period is 5 years.
Scientific/Research Contacts Basil Eldadah, M.D., Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-6761
Email: eldadahb@nia.nih.gov
Title: NIH Blueprint Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP-ENDURE) (R25 Clinical Trial Not Allowed)
Notice Number:
 
RFA-NS-20-015
Issued by: NIA, NINDS and select other institutes
Activity Code: R25
Description The over-arching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research 
To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:

  • Research Experiences
  • Mentoring Activities
  • Courses for Skills Development
Open Date (Earliest Submission Date): January 19, 2020
Letters of Intent Due Date: January 19, 2020
Application Due Date(s) February 19, 2020
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
The NIH Blueprint Institutes intend to commit $1 million in FY2020 to fund 3-4 awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. 
 
Award Budget: Although the size of award may vary with the scope of the research education program proposed and there are no specific budget limitations, the requested direct costs must be reasonable, well documented, fully justified and commensurate with the scope of the proposed program. The average cost per program is estimated between $250K - $300K.
Award Project Period: The total project period for an application submitted in response to this funding opportunity may not exceed 5 years.
Scientific/Research Contacts Michelle D. Jones-London, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-451-7966
Email: jonesmiche@mail.nih.gov
Title: Impact of Alcohol on the Onset and Progression of Alzheimer’s Disease and Its Related Dementias (R01 - Clinical Trial Optional)
Notice Number:
 
RFA-AA-20-006
Issued by: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Aging (NIA)
Activity Code: R01
Description The goal of this FOA is to support basic and clinical research on the influence of alcohol on susceptibility and progression of Alzheimer's disease and its related dementias.
 
With this FOA, we solicit research projects that combine diverse expertise and use innovative approaches to investigate mechanisms by which alcohol affects brain aging processes to produce dementias and influences development of Alzheimer's disease. This FOA strongly encourages collaborations between alcohol researchers and experts in Alzheimer's disease and its related dementia research
Open Date (Earliest Submission Date): February 24, 2020
Letters of Intent Due Date: February 24, 2020
Application Due Date(s) March 24, 2020
Funds Available and Anticipated Number of Awards Issuing IC and partner components intend to commit an estimated total of $3 million to fund 6 - 8 awards.
Award Budget: Application budgets need to reflect the actual needs of the proposed project. The budgets are limited to $250,000 direct coasts annually
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Scientific/Research Contacts Changhai Cui, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-1678
Email: changhai.cui@nih.gov
Bradley C. Wise, Ph.D.
National Institute of Aging (NIA)
Telephone:301-496-9350
Email: WiseB@nia.nih.gov
 
Title: Notice of Participation of the National Institute on Aging (NIA) in PAR-19-343 Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent CT Not Allowed)
Notice Number:
 
NOT-AG-20-009
Issued by: National Institute on Aging (NIA)
Description NIA participates in NIH-wide programs to increase diversity in the research workforce. The goal of this FOA is to help outstanding postdoctoral researchers who are considered under-represented minority in science to transition into independent, tenure-track or equivalent faculty positions.  NIA welcomes applications in all fields of aging research, including basic science, diseases and disabling conditions of aging, the social and behavioral consequences of an aging society, and topics in between. A particular priority of NIA at the moment is research on Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD).
Open Date (Earliest Submission Date): Jan. 12, 2020
Letters of Intent Due Date: n/a
Application Due Date(s) Standard dates apply, by 5:00 PM local time of applicant organization. 
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
 
 
Award Budget: Salary Support: NIA will provide K99 salary support commensurate with the applicant institution's salary structure for persons of equivalent qualifications, experience, and rank for up to $75,000 plus fringe benefits per year.
 
Research Support: NIA will provide up to $25,000 research support per year for the K99 phase of the award.
 
Other Program-Related Expenses: TRAVEL: The application may request up to $2,500 annually to defray the cost of participation in professional meetings (excluding MOSAIC associated meetings, the costs of which will be covered by the UE5 awardees).
Award Project Period: The total project period may not exceed 5 years.
Scientific/Research Contacts Shahrooz Vahedi, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-9322
Email: shahrooz.vahedi@nih.gov
Title: Notice of Special Interest: Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
Notice Number:
 
NOT-OD-20-048
Issued by: National Institute on Aging (NIA)
National Institute of Neurological Disorders and Stroke (NINDS)
(and many NIH institutes)
Activity Code: Administrative Supplement
Description The Office of Research on Women's Health (ORWH) announces the availability of administrative supplements to support research highlighting health disparities among women in the US who are underrepresented, understudied, and underreported (U3) in biomedical research. The proposed research must address at least one objective from the strategic goals 1, 2, or 3 of the 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women."
Open Date (Earliest Submission Date): (2018)
Letters of Intent Due Date: n/a
Application Due Date(s) Due dates may vary by awarding IC.  See the awarding IC's web site for any applicable Application Due Dates.  
Award Budget: $2,000,000 is expected to be available annually for funding this program. The budget should not exceed $140,000 direct costs for the administrative supplement per year. In addition to the direct cost, applicable F&A (indirect) cost can also be requested.
The application budget is limited to one year only.  Supplements may provide support above the dollar limits of the funding opportunity announcement of the parent grant award.
Scientific/Research Contacts Rajasri Roy Ph.D., MPH
Office of Research on Women's Health (ORWH)
Telephone: 301-451-0993
Email: rajasri.roy@nih.gov
Title: Notice of Special Interest: Administrative Supplements for Research on Sex/Gender Influences (Admin Supp Clinical Trial Optional)
Notice Number:
 
NOT-OD-20-049
Issued by: National Institute on Aging (NIA)
National Institute of Neurological Disorders and Stroke (NINDS)
(and many NIH institutes)
Activity Code: Administrative Supplement
Description The Office of Research on Women's Health (ORWH) announces the availability of administrative supplements to support research highlighting the impact of sex and gender influences in human health and illness. Sex and gender are important considerations in many areas of research, including basic biological, psychological, social, and behavioral studies. With continuous interaction between sex and gender, human health is determined by both biology and expression of gender. The most robust experimental designs include consideration of both sex and gender; therefore, applications proposing to investigate the influence of both sex and gender factors are highly encouraged. The proposed research must address at least one objective from the five strategic goals of the 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women".
Open Date (Earliest Submission Date): (2018)
Letters of Intent Due Date: n/a
Application Due Date(s) Due dates may vary by awarding IC.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets are limited to no more than the amount of the current parent award, and must reflect the actual needs of the proposed project.
Award Project Period: The project and budget periods must be within the currently approved project period for the existing parent award.   
Scientific/Research Contacts For any scientific or research-related questions on this administrative supplement notice please contact the Program Officer listed on the NoA of the most recent parent award.
Title: Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional)
Notice Number:
 
PAR-20-070
Issued by: National Institute on Aging (NIA)
Activity Code: R21/R33 Phased Innovation Award
Description This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. This FOA will use the NIH Phased Innovation Award (R21/R33) mechanism to provide up to 2 years of R21 support for initial developmental activities and up to 3 years of R33 support for expanded activities. Through this award, investigators will develop a sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.
Open Date (Earliest Submission Date): Jan. 16, 2020
Letters of Intent Due Date: n/a
Application Due Date(s) Standard dates apply, by 5:00 PM local time of applicant organization.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Project Period: The duration of the entire R21/R33 award may not exceed 5 years. The R21 phase may not exceed 2 years of support. The R33 phase may not exceed 3 years of support.
Scientific/Research Contacts Winifred K. Rossi
National Institute on Aging (NIA)
Telephone: 301-496-3836
Email: rossiw@mail.nih.gov
Title: Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
Notice Number:
 
PAR-20-071
Issued by: National Institute on Aging (NIA)
Activity Code: R33 Exploratory/Developmental Grants Phase II.
Description This FOA invites applications that propose to support advanced-stage development and utilization of novel research infrastructure to advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations. This FOA will use the NIH Exploratory/Developmental Grants Phase II mechanism to provide support for expanded activities. Applicants are expected to have an existing research infrastructure developed, either through PA-12-064 or with other NIH or non-NIH support. Through this award, investigators will develop a mature and sustainable research infrastructure to support projects that address key interdisciplinary aging research questions.
Open Date (Earliest Submission Date): Jan. 16, 2020
Letters of Intent Due Date: n/a
Application Due Date(s) Standard dates apply. The first application due date for this FOA is February 16, 2020.
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets may not exceed $499,999   in annual direct costs.
Award Project Period: The duration of the R33 award may not exceed 5 years.
Scientific/Research Contacts Winifred K. Rossi
National Institute on Aging (NIA)
Telephone: 301-496-3836
Email: rossiw@mail.nih.gov
Title: Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed)
Notice Number:
 
PAR-20-076
Issued by: National Institute of Neurological Disorders and Stroke 
National Institute on Aging 
National Institute on Drug Abuse 
National Institute of Mental Health 
Activity Code: T32 Institutional National Research Service Award (NRSA)
Description The Jointly Sponsored NIH Predoctoral Training Program in the Neurosciences (JSPTPN) is an institutional program that supports broad and fundamental research training in the neurosciences. In addition to a broad education in the neurosciences, a key component will be a curriculum that provides a strong foundation in experimental design, statistical methodology and quantitative reasoning. JSPTPN programs are intended to be 2 years in duration and students may only be appointed to this training grant during the first 2 years of their graduate research training. The primary objective is to prepare students to be outstanding scientists equipped to pursue careers in neuroscience.
Open Date (Earliest Submission Date): April 26, 2020
Letters of Intent Due Date: 30 days prior to the application due date.
Application Due Date(s) May 26, 2020; May 25, 2021; May 25, 2022
Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets are not limited, but need to reflect the actual needs of the proposed project.
Award Project Period: Up to 5 years
Scientific/Research Contacts Applicants should refer to the (JSPTPN website) for each IC's scientific/research contact for this NRSA T32 program. Applicants should contact the Chair of the JSPTPN Steering Committee with questions about this FOA or the application itself.
Title: Impact of Alcohol on the Onset and Progression of Alzheimers Disease and Its Related Dementias (R01 - Clinical Trial Optional)
Notice Number:
 
RFA-AA-20-006
Issued by: National Institute on Alcohol Abuse and Alcoholism 
National Institute on Aging
Activity Code: R01 Research Project Grant
Description The goal of this FOA is to support basic and clinical research on the influence of alcohol on susceptibility and progression of Alzheimer's disease and its related dementias. Recent longitudinal studies have provided strong evidence that alcohol use disorder is associated with the high risk of all types of dementias, and frequent heavy drinking increases risk of both Alzheimer's disease and vascular dementia. Even moderate alcohol consumption may be a risk factor for adverse brain outcomes and cognitive decline. Although these studies link heavy and frequent alcohol drinking to dementias in aging populations, mechanisms contributing to this relationship are not well understood. With this FOA, we solicit research projects that combine diverse expertise and use innovative approaches to investigate mechanisms by which alcohol affects brain aging processes to produce dementias and influences development of Alzheimer's disease. This FOA strongly encourages collaborations between alcohol researchers and experts in Alzheimer's disease and its related dementia research
Open Date (Earliest Submission Date): Feb. 24, 2020
Letters of Intent Due Date: Feb. 24, 2020
Application Due Date(s) March 24 2020
Funds Available and Anticipated Number of Awards Issuing IC and partner components intend to commit an estimated total of $3 million to fund 6 - 8 awards.
Award Budget: Application budgets need to reflect the actual needs of the proposed project. The budgets are limited to $250,000 direct coasts annually
Award Project Period: The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Scientific/Research Contacts Changhai Cui, Ph.D.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-1678
Email: changhai.cui@nih.gov
Bradley C. Wise, Ph.D.
National Institute of Aging (NIA)
Telephone:301-496-9350
Email: WiseB@nia.nih.gov
Title: BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
Notice Number:
 
RFA-NS-19-043
Issued by: NIA NINDS and others
Activity Code: K99/R00 Career Transition Award/Research Transition Award
Description The purpose of the NIH BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to enhance workforce diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators from diverse backgrounds in BRAIN Initiative research areas
 
This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor. Applicants proposing a clinical trial or an ancillary study to an ongoing clinical trial as lead investigator, should apply to the companion FOA RFA-NS-19-044  .
Open Date (Earliest Submission Date): Jan. 9, 2020
Letters of Intent Due Date: n/a
Application Due Date(s) New
February 10, 2020, June 10, 2020, October 9, 2020; February 10, 2021; June 9, 2021; October 6, 2021; February 10, 2022; June 8, 2022; October 11, 2022
Resubmission
March 10, 2020, July 10, 2020, November 10, 2020; March 10, 2021; July 8, 2021; November 08, 2021; March 10, 2022; July 8, 2022; November 11, 2022
 
Funds Available and Anticipated Number of Awards The BRAIN Initiative intends to commit $4.0M per year in fiscal years 2020-2023 to fund an estimate of 20 awards per year.
Award Budget: Award budgets are composed of salary and other program-related expenses. See full FOA for details.
Award Project Period: The total project period may not exceed 5 years.
Scientific/Research Contacts For project relevance or scientific questions:
Edmund (Ned) Talley, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1917
Email: BRAINDIVERSITYK99R00@nih.gov
For mechanism or career development questions:
Michelle Jones-London, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-451-7966
Email: BRAINDIVERSITYK99R00@nih.gov
 
Title: BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required)
Notice Number:
 
RFA-NS-19-044
Issued by: NINDS, NIA and others
Activity Code: K99/R00 Career Transition Award/Research Transition Award
Description The purpose of the NIH BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) program is to enhance workforce diversity in the neuroscience workforce and maintain a strong cohort of new and talented, NIH-supported, independent investigators from diverse backgrounds in BRAIN Initiative research areas.
This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to the companion FOA (RFA-NS-19-043)
 
Open Date (Earliest Submission Date): Jan 10, 2020
Letters of Intent Due Date: n/a
Application Due Date(s) New
February 10, 2020; June 10, 2020; October 9, 2020; February 10, 2021; June 9, 2021; October 6, 2021; February 10, 2022; June 8, 2022; October 11, 2022
Resubmission
March 10, 2020; July 10, 2020; November 10, 2020; March 10, 2021; July 8, 2021; November 08, 2021; March 10, 2022; July 8, 2022; November 11, 2022
 
Funds Available and Anticipated Number of Awards The BRAIN Initiative intends to commit $4.0M per year in fiscal years 2020-2023 to fund an estimate of 20 awards per year.
Award Budget: Award budgets are composed of salary and other program-related expenses. See full FOA for details.
Award Project Period: The total project period may not exceed 5 years.
Scientific/Research Contacts For project relevance or scientific questions:
Edmund (Ned) Talley, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1917
Email: BRAINDIVERSITYK99R00@nih.gov
For mechanism or career development questions:
Michelle Jones-London, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-451-7966
Email:BRAINDIVERSITYK99R00@nih.gov
 

*LBDA Policy on Indirect Rates
Grant proposals to LBDA should not exceed a 10% indirect rate; this is the maximum allowed for the primary applicant organization and any sub-grantees or contractors. (If a grantee has an indirect cost rate lower than 10%, they should not increase the funding to the maximum allowed.) LBDA reserves the right to allow for a higher indirect rate in rare situations as warranted. Written permission from LBDA’s contact person for the grant opportunity is required in advance of submitting a proposal with an indirect rate higher than 10%.